|
1
|
Zorov DB, Juhaszova M and Sollott SJ:
Mitochondrial ROS-induced ROS release: An update and review.
Biochim Biophys Acta. 1757:509–517. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zelko IN, Mariani TJ and Folz RJ:
Superoxide dismutase multigene family: A comparison of the CuZn-SOD
(SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures,
evolution, and expression. Free Radic Biol Med. 33:337–349. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wilcox CS: Reactive oxygen species: Roles
in blood pressure and kidney function. Curr Hypertens Rep.
4:160–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marks PA: Thioredoxin in cancer - role of
histone deacetylase inhibitors. Semin Cancer Biol. 16:436–443.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alexandre A and Lehninger AL: Bypasses of
the antimycin a block of mitochondrial electron transport in
relation to ubisemiquinone function. Biochim Biophys Acta.
767:120–129. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Campo ML, Kinnally KW and Tedeschi H: The
effect of antimycin A on mouse liver inner mitochondrial membrane
channel activity. J Biol Chem. 267:8123–8127. 1992.PubMed/NCBI
|
|
7
|
Balaban RS, Nemoto S and Finkel T:
Mitochondria, oxidants, and aging. Cell. 120:483–495. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Panduri V, Weitzman SA, Chandel NS and
Kamp DW: Mitochondrial-derived free radicals mediate
asbestos-induced alveolar epithelial cell apoptosis. Am J Physiol
Lung Cell Mol Physiol. 286:L1220–L1227. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Petronilli V, Penzo D, Scorrano L,
Bernardi P and Di Lisa F: The mitochondrial permeability
transition, release of cytochrome c and cell death. Correlation
with the duration of pore openings in situ. J Biol Chem.
276:12030–12034. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pastorino JG, Tafani M, Rothman RJ,
Marcinkeviciute A, Hoek JB and Farber JL: Functional consequences
of the sustained or transient activation by Bax of the
mitochondrial permeability transition pore. J Biol Chem.
274:31734–31739. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park WH, Han YW, Kim SH and Kim SZ: An ROS
generator, antimycin A, inhibits the growth of HeLa cells via
apoptosis. J Cell Biochem. 102:98–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park WH, Han YW, Kim SW, Kim SH, Cho KW
and Kim SZ: Antimycin A induces apoptosis in As4.1 juxtaglomerular
cells. Cancer Lett. 251:68–77. 2007. View Article : Google Scholar
|
|
13
|
King MA: Antimycin A-induced killing of
HL-60 cells: Apoptosis initiated from within mitochondria does not
necessarily proceed via caspase 9. Cytometry A. 63:69–76. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guha G, Mandal T, Rajkumar V and Ashok
Kumar R: Antimycin A-induced mitochondrial apoptotic cascade is
mitigated by phenolic constituents of Phyllanthus amarus aqueous
extract in Hep3B cells. Food Chem Toxicol. 48:3449–3457. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
You BR and Park WH: The effects of
antimycin A on endothelial cells in cell death, reactive oxygen
species and GSH levels. Toxicol In Vitro. 24:1111–1118. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han YH and Park WH: Growth inhibition in
antimycin A treated-lung cancer Calu-6 cells via inducing a G1
phase arrest and apoptosis. Lung Cancer. 65:150–160. 2009.
View Article : Google Scholar
|
|
17
|
Han YH, Kim SH, Kim SZ and Park WH:
Antimycin A as a mitochondrial electron transport inhibitor
prevents the growth of human lung cancer A549 cells. Oncol Rep.
20:689–693. 2008.PubMed/NCBI
|
|
18
|
Han YH and Park WH: Tiron, a ROS
scavenger, protects human lung cancer Calu-6 cells against
antimycin A-induced cell death. Oncol Rep. 21:253–261. 2009.
|
|
19
|
Han YH, Kim SZ, Kim SH and Park WH:
Pyrogallol inhibits the growth of lung cancer Calu-6 cells via
caspase-dependent apoptosis. Chem Biol Interact. 177:107–114. 2009.
View Article : Google Scholar
|
|
20
|
You BR and Park WH: Gallic acid-induced
lung cancer cell death is related to glutathione depletion as well
as reactive oxygen species increase. Toxicol In Vitro.
24:1356–1362. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
You BR, Kim SH and Park WH: Reactive
oxygen species, glutathione, and thioredoxin influence suberoyl
bishydroxamic acid-induced apoptosis in A549 lung cancer cells.
Tumour Biol. 36:3429–3439. 2015. View Article : Google Scholar
|
|
22
|
You BR, Shin HR, Han BR and Park WH: PX-12
induces apoptosis in Calu-6 cells in an oxidative stress-dependent
manner. Tumour Biol. 36:2087–2095. 2015. View Article : Google Scholar
|
|
23
|
Jia L, Allen PD, Macey MG, Grahn MF,
Newland AC and Kelsey SM: Mitochondrial electron transport chain
activity, but not ATP synthesis, is required for drug-induced
apoptosis in human leukaemic cells: A possible novel mechanism of
regulating drug resistance. Br J Haematol. 98:686–698. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Han YH, Kim SH, Kim SZ and Park WH:
Antimycin A as a mitochondria damage agent induces an S phase
arrest of the cell cycle in HeLa cells. Life Sci. 83:346–355. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han YW, Kim SZ, Kim SH and Park WH: The
changes of intra-cellular H2O2 are an
important factor maintaining mitochondria membrane potential of
antimycin A-treated As4.1 juxtaglomerular cells. Biochem Pharmacol.
73:863–872. 2007. View Article : Google Scholar
|
|
26
|
Gallegos A, Gasdaska JR, Taylor CW,
Paine-Murrieta GD, Goodman D, Gasdaska PY, Berggren M, Briehl MM
and Powis G: Transfection with human thioredoxin increases cell
proliferation and a dominant-negative mutant thioredoxin reverses
the transformed phenotype of human breast cancer cells. Cancer Res.
56:5765–5770. 1996.PubMed/NCBI
|
|
27
|
Kim SJ, Miyoshi Y, Taguchi T, Tamaki Y,
Nakamura H, Yodoi J, Kato K and Noguchi S: High thioredoxin
expression is associated with resistance to docetaxel in primary
breast cancer. Clin Cancer Res. 11:8425–8430. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Poljsak B and Raspor P: The antioxidant
and pro-oxidant activity of vitamin C and trolox in vitro: A
comparative study. J Appl Toxicol. 28:183–188. 2008. View Article : Google Scholar
|
|
29
|
Halliwell B: Vitamin C: Antioxidant or
pro-oxidant in vivo? Free Radic Res. 25:439–454. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Estrela JM, Ortega A and Obrador E:
Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci.
43:143–181. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Higuchi Y: Glutathione depletion-induced
chromosomal DNA fragmentation associated with apoptosis and
necrosis. J Cell Mol Med. 8:455–464. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Han YH and Park WH: The effects of
N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate
or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells
in relation to cell growth, reactive oxygen species and
glutathione. Oncol Rep. 22:385–391. 2009.PubMed/NCBI
|
|
33
|
Park WH and You BR: Enhancement of gallic
acid-induced human pulmonary fibroblast cell death by N-acetyl
cysteine and L-buthionine sulfoximine. Hum Exp Toxicol. 30:992–999.
2011. View Article : Google Scholar
|
